Running title: T cell surface CD4+ α-enolase in ageing 
INTRODUCTION
Biological ageing is a complex process influenced by genetic and environmental factors that varies in rate from person to person; chronological age is considered to be a poor indicator of the rate of biological ageing (1) . While the life spans of identical twins are significantly more similar than those of non-identical twins, genetic factors are only estimated to account for between a quarter and a third of life span (2) . Environmental factors including healthy diet and increased levels of physical activity have also been linked to longer life expectancy (3, 4) . Biomarkers represent an attractive measure of biological ageing and potentially may improve our understanding of underlying ageing processes and age-related disease (5) . Recent studies suggest that cell surface receptors may also be modified post-translationally, undergo changes in trafficking or level of expression (6) (7) (8) (9) . However, to date the cell surface proteome has not been investigated systematically for age-dependent biomarkers.
CD4
+ T cells are required for effective acquired immunity, and a decline in their function is thought to contribute to reduced efficacy of response to infection, vaccination, an increase in autoimmunity and cardiovascular disease typically seen with ageing (10) (11) (12) (13) (14) . This may in part be due to the age-related decrease in naïve and increase in antigen experienced CD4 + T cells (15, 16) . Given the observed age-related changes to CD4 + T cell function and the importance of cell surface receptor expression and binding for activation, the CD4 + T cell plasma membrane proteome may be an important source of biomarkers of ageing.
2DE provides a non-hypothesis driven proteomic approach for biomarker identification, which separates all protein isoforms within a sample at a given time point. The technique has been and centrifuged at 160 x g for 15 minutes. Plasma (5-10 mL) was removed and the preparation centrifuged for a further 20 minutes at 350 x g. PBMC (1-2 x 10 7 ) were pipetted into a clean centrifuge tube (Corning, UK) and washed twice with PBS with 0.1% w/v BSA to remove residual Lymphoprep. CD4 + T cells were isolated from PBMC using a negative isolation kit (Life Technologies, UK) yielding 5-7 x 10 6 cells. For analysis of gene expression, mRNA was harvested from CD4 + T cells using Trizol® reagent (Invitrogen, Carlsbad, CA). For the purpose of flow cytometry for cell surface antigens, whole blood (50µL) was fixed by addition of 500µL
OptiLyse C (Beckman Coulter) for 2 hours and then stored at -80°C prior to analysis. To determine total intra-and extra-cellular protein expression, fixed whole blood was incubated with 0.5% saponin in PBS, treated for 10 minutes prior to staining with appropriate antibodies.
Membrane protein preparation
Primary human CD4 + T cells (5 x 10 6 cells) were washed three times in ice cold PBS (1mL; pH 8) and cell surface proteins labelled with 0.5 mg/mL biotin (Sulfo-NHS-SS-Biotin, Thermo
Scientific, UK) for 20 minutes at 4 ºC on a rotary mixer. Cells were washed twice with glycine (10 mM) to quench the biotinylation reaction and washed once with PBS (pH 8). Cells were lysed on ice for 30 minutes in MNE (25mM MES (pH 6.5), 150mM NaCl, 2mM EDTA) lysis buffer supplemented with 1mM sodium orthovanadate, 1% v/v Triton X-100 and 0.1% v/v protease inhibitor cocktail (Sigma Aldrich, UK), genomic DNA was sheared using a 21 G needle (Terumo, UK) and centrifuged at 2,000 xg for 5 minutes to obtain a post-nuclear supernatant 
LC-MS/MS
Protein spots were prepared for protein identification using in gel digestion with trypsin (24) .
Flamingo fluorescence-stained spots were excised, divided into ~2 mm 3 cubes and destained with acetonitrile followed by 100 mM ammonium bicarbonate. This cycle was repeated until gel pieces were destained. Gel pieces were dried (vacuum centrifugation; 5 min) and rehydrated in 10 mM DTT and 100 mM ammonium bicarbonate and reduced at 60°C for 15 min. The liquid was removed and replaced with 50mM iodoacetamide and 100mM ammonium bicarbonate. Gel pieces were incubated at room temperature in the dark for 45 min and then washed with 100mM ammonium bicarbonate. After drying the gel (vacuum centrifugation; 5 min) 0.3 µg trypsin gold (Promega, WI, USA) was added and shaken at room temperature for 30 min, before dilution with 100 mM ammonium bicarbonate. Hydrolysis was allowed to occur overnight (~16 h) at 37 °C.
Peptides were extracted with the initial solution of 2% acetonitrile and 0.1% formic acid in water was added and shaken for 30 minutes. Supernatant was removed to a clean plate. A second peptide extraction was performed using 40% acetonitrile and 0.1% formic acid in water, shaken for 30 minutes at room temperature. The supernatant was removed, pooled with the previous extracted peptides and dried in an evaporator. The samples were re-suspended in 0.1% formic acid in water. Precursor ions were isolated and subjected to collision induced dissociation in the linear ion trap with automatic gain control 1x10 5 . Collision activation for the experiment was performed in the linear trap using helium gas at normalized collision energy to precursor m/z of 35% and activation Q 0.25. The width of the precursor isolation window was 2 m/z and only multiplycharged precursor ions were selected for MS/MS.
The MS and MS/MS scans were searched against NCBI database using the Mascot algorithm (Matrix Sciences). Variable modifications were deamidation (N and Q), oxidation (M), carboxyamidomethylation (C) and protein linker (K). The precursor mass tolerance was 10 ppm and the MS/MS mass tolerance was 0.8Da. Two missed cleavage was allowed and were accepted as a real hit protein with at least two high confidence peptides.
Western blotting analysis
Proteins (5 µg) were separated by SDS-PAGE using 10 % polyacrylamide gels and transferred to
Hybond-P membrane (GE Healthcare, UK) as previously described (24 
Data analysis
For comparison of values between young and older adult male groups, data from each group was checked for normality using the Kolmogorov-Smirnov test. A parametric independent samples ttest was applied to the data and significance set at p < 0.05. Where necessary, data were log transformed. Data was analysed using SPSS statistical package version 20.0 for Windows (SPSS Inc, USA).
Biotinylation of primary CD4 + T cells using Sulfo-NHS-SS Biotin reagent
Using 
Purification of T cell plasma membrane proteins
To confirm the specificity of the method described by Zhao and colleagues (20) for recovery of plasma membrane but not cytosolic proteins, unlabelled cells from a Jurkat T cell line were incubated with streptavidin magnetic beads as a negative control. In these experiments no purified membrane or total protein was observed (data not shown). CD3, LDH and β-actin were used as markers of CD4 + T cell plasma membrane, cytosolic and cytoskeletal proteins respectively. As shown in Figure 2 , after labelling exofacial proteins with biotin and purification using SA beads, CD4 + T cell plasma membrane proteins (e.g. CD3) are present in the PNS and SA-bead elution fraction but absent in the unbound fraction, whereas cytosolic proteins (e.g.
LDH) are present in the unbound fraction and absent in the SA-bead eluate. Cytoskeletal proteins (e.g. β-actin) are prominent in PNS and unbound fraction and greatly reduced in the eluate from SA beads. Together these data suggest that CD4 + T cell plasma membrane proteins are considerably separated from cytosolic and cytoskeletal contaminants using this technique.
Age associated differences in human CD4 + T cell membrane proteome
Healthy, non-smoking young (aged 18-35 years old) and older adult males (50-70 years old),
were recruited for analysis of the human CD4 + T cell membrane proteome. Biochemical and anthropometric measurements confirmed that there were no significant differences observed between the two age groups for blood glucose, total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides or body mass index (Table 1) .
To assess age related differences between young and older adult males, CD4 + T cells were isolated from whole blood and membrane proteins extracted (described in experimental procedures section). Equal amounts of membrane proteins from young and older adult T cells were pooled into two age-defined groups and separated by 2DE (Figure 3 ). Differences to seventeen protein spots (ten spot densities increased and seven decreased in the older adult group when compared to the young adult group) were observed between young and older adults when criteria p < 0.05 and > 1.4 fold difference was applied. Four discrete and abundant spots which could be accurately excised, were analysed LC-MS/MS and protein identification was achieved for two spots as summarized in Table 2 , including human α-enolase.
Validation of age related differences to CD4 + T cell membrane α-enolase and total enolase expression by flow cytometry and qPCR
To validate the protein expression difference identified by 2DE analysis in whole blood, cell surface levels of α-enolase on CD4 + T cells between an independent group of young (n=8) and older (n =11) male adults was analysed by flow cytometry. There were no significant differences observed between the two age groups for blood glucose, total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides or body mass index and anthropometric data for these samples can be found in supplementary Table 1 Figure 4D ). The decrease in cellular α-enolase expression in older adults was evident at the level of mRNA expression in older adults (p=0.029, Figure 4E ).
Cardiovascular associated differences in CD4 + T cell membrane α-enolase
To investigate whether the loss in α-enolase on CD4 + T cells during ageing was related to health status and knowing that α-enolase is a plasminogen activator, we examined α-enolase expression in a case-control study of age-matched cardiovascular disease patients. There was no significant difference in age between case and control groups. A significant reduction (p=0.018) in α-enolase on CD4 + T cells was demonstrated in cardiovascular disease patients ( Figure 4F ).
DISCUSSION
To our knowledge this is the first study to demonstrate (a) primary CD4 + T cell membrane protein enrichment and isolation using a biotinylation reagent; (b) age-related differences in α-enolase expression; and (c) cardiovascular disease-associated loss of α-enolase at the CD4 + T cell membrane. Ageing and cardiovascular disease are associated with a decline in specific acquired immune response. Recent studies have indicated an immune-modulatory role for surface α-enolase (25) . Our findings suggest that further investigation of surface α-enolase function on specific subsets of CD4 + T cells during these conditions is merited to explore the potential contribution of α-enolase-dependent function immune decline.
Using a previously described biotinylation enrichment method (19) (20) , we labelled lysine residues at the CD4 + T cell membrane with an impermeable biotinylation reagent which contains a disulphide bond. This disulphide bond becomes reduced in the intracellular environment, and thus on cell entry, no biotin is bound to lysine residues present on intracellular proteins. We provide evidence of a membrane protein fraction devoid of cytosolic protein contamination from primary CD4 + T cells by western blotting and confocal microscopy. The main purpose of this study was to identify age-related differences to the CD4 + T cell membrane proteome by 2DE.
Protein expression profiles for CD4 + T cell membrane proteins were compared between young and older male adult groups. In total, seventeen protein spots were altered and from four protein spots which could be accurately excised, one protein, α-enolase which was identified by LC-MS/MS, was decreased significantly in the older age group.
Intracellularly, α-enolase is known as a key glycolytic enzyme, responsible for catalysing the dehydration of 2-phosphoglycerate to phosphoenolpyruvate in the final steps of glycolysis. Aside from this well documented glycolytic activity, α-enolase has also more recently been implicated in many other biological and physiological processes (for a comprehensive review the reader is directed to Diaz-Ramos et al. (26)). α-Enolase has been detected on the surface of vascular endothelium (27) various cell types including monocytes, macrophages, B cells and T cells (28) and is recognized as a plasminogen receptor.
Interaction between plasminogen and α-enolase at the cell surface has been shown to enhance its activation and concentrate plasmin-associated protease activity. A previous study undertaken by Aillaud and colleagues (29) in 20 young and 20 elderly individuals reported an age associated increase in the plasma level of plasminogen activator inhibitor-1, which inhibits plasmin production from plasminogen, with a likely increase in propensity for clotting; there is evidence that this is further increased in healthy centenarians compared to healthy elderly individuals (30).
Another reported function for plasmin lies in the processing of integrins and therefore a decrease in localised plasminogen activation, following from loss of α-enolase on older adult T cells, may affect cell migration (31).
The surface difference in α-enolase expression identified by 2DE approaches was verified in whole blood taken from volunteers of different ages by flow cytometry. The loss of enolase spot volume by 2DE may be in part due to a post-translational modification which altered enolase migration in the gel. However, we confirmed that there was significantly lower surface enolase expression in a second independent cohort of 8 young and 11 older adults. This proof of concept was undertaken by analysis of individual subject CD4+ T cells using an antibody-based, flow cytometric method which did not require any pre-extraction of sample. The distribution of α-enolase was generally lower in older adults with a noticeable loss of CD4 + cells that expressed high levels of α-enolase. This may reflect an age-associated difference in specific CD4 + subset frequency (32) which merits future investigation for association with specific T cell subsets and effects on function. While it could reflect a more generalised failure to traffic α-enolase to the surface in ageing T cells, this is less likely as our data suggests that α-enolase mRNA transcription is lower in T cells from older adults. Lower α-enolase expression with ageing implies a more refractory phenotype as T cells tend to tune down glycolysis in a resting state because higher energy flux with ATP production is not required for non-proliferating cells (33).
The association of α-enolase with caveolar proteins, present in lipid rafts, regulates its subcellular localization (34). In ageing T cells fewer proteins are associated in rafts in the resting state but there is a failure of protein mobility within rafts during activation (35). This contrasts with senescent endothelial cells which showed significantly increased numbers of caveolae and associated proteins and promotion of anti-inflammatory pathways (36).
The health-status of the young and older populations studied here were self-declared and based on lack of regular medication, however, the α-enolase expression was not always lower than the 5 th percentile of young adult expression. To investigate whether this is associated with vascular disease, we explored the expression of T cell surface α-enolase in cardiovascular disease patients compared to age-matched controls. In common with ageing, the presence of vascular disease in patients aged between 50 and 72 years was also associated with even lower surface α-enolase expression compared to age-matched healthy controls. There is increasing interest in the role of T cells within the arterial wall and they have been implicated in the genesis of hypertension, vascular dysfunction, and cardiac fibrosis (37, 38). Indeed, Tregs were shown to ameliorate hypertension-driven vascular dysfunction through a paracrine-dependent mechanism raising a possible role for T cell-mediated therapeutics for vascular disease (14, 38) .
In addition to a difference in α-enolase expression, several other proteins were identified as altered between the young and older groups and excised for LC-MS/MS analysis. One protein spot appears to be two proteins of similar molecular weights and isoelectric point; both prointerleukin-16 and T-complex protein 1 subunit alpha were identified with high peptide cleavage and sequence coverage. A further two excised spots were unidentified. To improve speed of peptide extraction, recovery and coverage from excised membrane proteins we used an acidlabile surfactant during tryptic digestion. However, the frequency of arginine and lysine residues is less in hydrophobic membrane proteins, resulting in fewer potential tryptic cleavage sites which may have contributed to our difficulty in identifying them. This was likely further compounded by labelling of lysine residues with biotin reagent for membrane protein enrichment of samples thereby reducing the available number of cleavage sites.
Here, reduced α-enolase levels at the CD4 + T cell surface were observed in a healthy older compared to young male group and in a cardiovascular disease group compared to age-matched controls. Lower α-enolase levels in older adults may impact on plasminogen concentration at the T cell surface, plasminogen activation, plasmin proteolytic activity and plasmin-mediated intracellular signalling. Since lower surface α-enolase is evident during healthy ageing and is lowered further in cardiovascular disease patients, its role in predisposition to vascular disease in older adults merits further investigation.
CONCLUSION
Using subcellular fractionation and gel-based proteomics, we have shown that cell surface expression of α-enolase is lower in older adults compared to younger people and in cardiovascular disease. This is the first study to identify an alteration in the expression of α-enolase on the CD4 + T cell surface. Whether this impacts on the plasmin/plasminogen proteolytic system and T cell function remains to be investigated. and data analysis was performed using Progenesis SameSpots software. Arrows indicate four discrete and abundant spots, altered between young and older groups, which were excised for protein identification by LC-MS/MS. Spot numbers correspond to spot identification numbers in Table 2 . 
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